Replies to post #8929 on Tetra Bio Pharma Inc (TBPMQ)

[ClosetInvestor]

“Plenitude© is a 4-week double-blind, randomized, placebo-controlled, parallel group design trial to evaluate the safety and efficacy of inhaled QIXLEEF™ to relieve uncontrolled cancer related pain in 78 adult patients with advanced incurable disease.”

I’d like to get an update on this trial. The last update was in September of 2020 and the company announced the trial had started. Clinicaltrials.gov says trial completion date is September of 2021. The PR said there are 10 clinical trial sites so I expected it should enroll quickly.